Cardiac granular cell neoplasm

disease
On this page

Also known as Cardiac granular cell tumorCardiac granular cell tumourgranular cell neoplasm of heartgranular cell neoplasm of the heartgranular cell tumor of heartgranular cell tumor of the heartgranular cell tumour of heartgranular cell tumour of the heartheart granular cell tumorheart granular cell tumour

Summary

Cardiac granular cell neoplasm (MONDO:0003254) is a cancer. A subtype of benign granular cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecardiac granular cell neoplasm
Mondo IDMONDO:0003254
DOIDDOID:5044
NCITC5360
UMLSC1332845
MedGen232023
GARD0023425
Anatomy (UBERON)UBERON:0000948
Is cancer (heuristic)yes

Also known as: Cardiac granular cell neoplasm · Cardiac granular cell tumor · Cardiac granular cell tumour · granular cell neoplasm of heart · granular cell neoplasm of the heart · granular cell tumor of heart · granular cell tumor of the heart · granular cell tumour of heart · granular cell tumour of the heart · heart granular cell tumor · heart granular cell tumour

Disease family

Classification path: disease › human disease › disease by body system or component › nervous system disorderperipheral nervous system disorderperipheral nervous system neoplasmnerve sheath neoplasmgranular cell tumor › benign granular cell tumor › cardiac granular cell neoplasm

Related subtypes (1): benign peripheral nerve granular cell tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.